Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07PBZ
|
||||
| Former ID |
DAP000202
|
||||
| Drug Name |
Epoetin alfa
|
||||
| Synonyms |
Epogen (TN); Procrit (TN)
|
||||
| Indication | Anemia [ICD9: 280-285; ICD10:D50-D64] | Approved | [538380] | ||
| Therapeutic Class |
Antianemic Agents
|
||||
| Company |
Amgen Inc
|
||||
| Formula |
C815H1317N233O241S5
|
||||
| CAS Number |
CAS 113427-24-0
|
||||
| SuperDrug ATC ID |
B03XA01
|
||||
| Target and Pathway | |||||
| Target(s) | Erythropoietin Receptor | Target Info | Agonist | [535660], [537090] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Signaling events mediated by Stem cell factor receptor (c-Kit) | ||||
| EPO signaling pathway | |||||
| WikiPathways | EPO Receptor Signaling | ||||
| References | |||||
| Ref 535660 | Knockouts model the 100 best-selling drugs--will they model the next 100? Nat Rev Drug Discov. 2003 Jan;2(1):38-51. | ||||
| Ref 537090 | 2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. PediatrBlood Cancer. 2009 Jul;53(1):7-12. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.